WOODCLIFF LAKE, N.J. — Par Pharmaceutical on Tuesday announced that it has started shipping amlodipine and valsartan tablets in all four dosage strengths. The tablets are the generic version of Exforge from Novartis and are used to treat hypertension.
The tablets also are indicated to lower blood pressure in patients not controlled on monotherapy and as initial therapy in patients who likely need multiple drugs to achieve their blood-pressure goals, the company stated. U.S. sales of Exforge totaled approximately $422 million, according to IMS Health data.